Stem Cell Research News: News on Stem Cell Research continually updated from thousands of sources around from the B Media Network.
Pages
▼
Thursday, July 24, 2014
Merck Initiates Phase 3 Study of Letermovir, an Investigational...
Merck , known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir , an investigational antiviral agent.
No comments:
Post a Comment